| 1 |
World Health Assembly. Resolution WHA 45.17. Immunization and Vaccine Quality. Geneva: World Health Assembly, 1992.
|
| 2 |
Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990;8 Suppl:S18-S20.
DOI
ScienceOn
|
| 3 |
Safary A, Beck J. Vaccination against hepatitis B: current challenges for Asian countries and future directions. J Gastroenterol Hepatol 2000;15:396-401.
DOI
ScienceOn
|
| 4 |
Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859.
DOI
ScienceOn
|
| 5 |
Wang WL, Shu ZJ, Zhou LX, Zhao YR. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China. Arch Virol 2012;157:901-905.
DOI
|
| 6 |
Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010;53:20-28.
DOI
ScienceOn
|
| 7 |
Kim H, Shin AR, Chung HH, et al. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 2013;28:413-419.
DOI
ScienceOn
|
| 8 |
Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985;318:323-329.
DOI
ScienceOn
|
| 9 |
Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-1339.
DOI
ScienceOn
|
webmaster
